http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104341362-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8be5426d28d133971ca0924ed527ea46 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 |
filingDate | 2014-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104341362-A |
titleOfInvention | Triazole sulfonyl malonate compound, its preparation method and use |
abstract | The invention relates to the field of medicines related to hyperuricemia and gout. Specifically, the present invention relates to a class of uric acid transporter 1 inhibitors containing a triazole sulfonyl malonate structure, a preparation method thereof, a pharmaceutical composition containing them and their application in the preparation of diabetes medicines. Wherein, R is selected from H, C 1 -C 8 alkyl, C 3 -C 6 cycloalkyl. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109134391-A |
priorityDate | 2014-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.